Pathology and Diagnostic Imaging Services in New Zealand - Industry Market Research Report

Pathology and Diagnostic Imaging Services in New Zealand - Industry Market Research Report

Pathology and Diagnostic Imaging Services in New Zealand

Revenue for the Pathology and Diagnostic Imaging Services industry has increased over the past five years. Diagnostic imaging and pathology play a critical role in providing health practitioners with results that support medical diagnosis and treatment, particularly for life-threatening issues such as cancer. Growth in the population aged 50 and older is driving demand, as older patients are more susceptible to chronic illnesses and diseases and require increased regular screenings. Revenue is expected to rise at an annualised 4.7% over the five years through 2022-23, to reach an estimated $1,034.8 million and an expected 2.6% revenue rise in 2022-23.

The industry primarily provides pathology laboratory or diagnostic imaging services, including body fluid analysis, ultrasounds and X-rays. Clinics and laboratories that primarily operate inside hospitals are not included in the industry.

This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.